Molecular genetic studies of gene identification for osteoporosis

References

• Liu YJ, Shen H, Xiao P et al. Molecular genetic studies of gene identification for osteoporosis: a 2004 update. J. Bone Miner. Res.21(10), 1511–1535 (2006).
   PubMed Web of Science ®Google Scholar
• Liu YZ, Liu YJ, Recker RR et al. Molecular studies of identification of genes for osteoporosis: the 2002 update. J. Endocrinol.177(2), 147–196 (2003).
   PubMed Web of Science ®Google Scholar
• Eichner JE, Friedrich CA, Cauley JA et al. A 2-HS glycoprotein phenotypes and quantitative hormone and bone measures in postmenopausal women. Calcif. Tissue Int.47(6), 345–349 (1990).
   PubMedGoogle Scholar
• Jia L, Ho NC, Park SS et al. Comprehensive resource: skeletal gene database. Am. J. Med. Genet.106(4), 275–281 (2001).
   PubMedGoogle Scholar
• Shen H, Liu Y, Liu P et al. Nonreplication in genetic studies of complex diseases – lessons learned from studies of osteoporosis and tentative remedies. J. Bone Miner. Res.20(3), 365–376 (2005).
   PubMed Web of Science ®Google Scholar
• Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet.20(9), 439–444 (2004).
   PubMed Web of Science ®Google Scholar
• Mitra S, Desai M, Ikram KM. Vitamin D receptor gene polymorphisms and bone mineral density in postmenopausal Indian women. Maturitas55(1), 27–35 (2006).
   PubMed Web of Science ®Google Scholar
• Palomba S, Orio F Jr, Russo T et al. BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial Osteoporos. Int.16(8), 943–952 (2005).
   PubMed Web of Science ®Google Scholar
• Horst-Sikorska W, Kalak R, Wawrzyniak A et al. Association analysis of the polymorphisms of the VDR gene with bone mineral density and the occurrence of fractures. J. Bone Miner. Metab.25(5), 310–319 (2007).
   PubMed Web of Science ®Google Scholar
• Grundberg E, Lau EM, Pastinen T et al. Vitamin D receptor 3´ haplotypes are unequally expressed in primary human bone cells and associated with increased fracture risk: the MrOS Study in Sweden and Hong Kong. J. Bone Miner. Res.22(6), 832–840 (2007).
   PubMed Web of Science ®Google Scholar
• Falchetti A, Sferrazza C, Cepollaro C et al. FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif. Tissue Int.80(1), 15–20 (2007).
   PubMed Web of Science ®Google Scholar
• Macdonald HM, McGuigan FE, Stewart A et al. Large-scale population-based study shows no evidence of association between common polymorphism of the VDR gene and BMD in British women. J. Bone Miner. Res.21(1), 151–162 (2006).
   PubMed Web of Science ®Google Scholar
• Uitterlinden AG, Ralston SH, Brandi ML et al. The association between common vitamin D receptor gene variations and osteoporosis: a participant-level meta-analysis. Ann. Intern. Med.145(4), 255–264 (2006).
   PubMed Web of Science ®Google Scholar
• Fang Y, Rivadeneira F, van Meurs JB et al. Vitamin D receptor gene BsmI and TaqI polymorphisms and fracture risk: a meta-analysis. Bone39(4), 938–945 (2006).
   PubMed Web of Science ®Google Scholar
• Albagha OM, Pettersson U, Stewart A et al. Association of oestrogen receptor a gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J. Med. Genet.42(3), 240–246 (2005).
   PubMed Web of Science ®Google Scholar
• Wang CL, Tang XY, Chen WQ et al. Association of estrogen receptor a gene polymorphisms with bone mineral density in Chinese women: a meta-analysis. Osteoporos. Int.18(3), 295–305 (2007).
   PubMed Web of Science ®Google Scholar
• Lai BM, Cheung CL, Luk KD et al. Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women. Osteoporos. Int. (2007). (Epub ahead of print).
   Google Scholar
• Mann V, Hobson EE, Li B et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J. Clin. Invest.107(7), 899–907 (2001).
   PubMed Web of Science ®Google Scholar
• Lohmueller KE, Pearce CL, Pike M et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat. Genet.33(2), 177–182 (2003).
   PubMed Web of Science ®Google Scholar
• Ralston SH, Uitterlinden AG, Brandi ML et al. Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med.3(4), E90 (2006).
   PubMed Web of Science ®Google Scholar
• Yamada Y, Ando F, Niino N et al. Association of a -1997G–>T polymorphism of the collagen Iα1 gene with bone mineral density in postmenopausal Japanese women. Hum. Biol.77(1), 27–36 (2005).
   PubMed Web of Science ®Google Scholar
• Yazdanpanah N, Rivadeneira F, van Meurs JB et al. The -1997 G/T and Sp1 polymorphisms in the collagen type I α1 (COLIA1) gene in relation to changes in femoral neck bone mineral density and the risk of fracture in the elderly: the Rotterdam study. Calcif. Tissue Int.81(1), 18–25 (2007).
   PubMedGoogle Scholar
• Tzakas P, Wong BY, Logan AG et al. Transforming growth factor β-1 (TGFβ1) and peak bone mass: association between intragenic polymorphisms and quantitative ultrasound of the heel. BMC Musculoskelet. Disord.6, 29 (2005).
   PubMedGoogle Scholar
• Long JR, Liu PY, Lu Y et al. Tests of linkage and/or association of TGF-β1 and COL1A1 genes with bone mass. Osteoporos. Int.16(1), 86–92 (2005).
   PubMedGoogle Scholar
• McGuigan FE, Macdonald HM, Bassiti A et al. Large-scale population-based study shows no association between common polymorphisms of the TGFB1 gene and BMD in women. J. Bone Miner. Res.22(2), 195–202 (2007).
   PubMedGoogle Scholar
• Bustamante M, Nogues X, Enjuanes A et al.COL1A1, ESR1, VDR and TGFB1 polymorphisms and haplotypes in relation to BMD in Spanish postmenopausal women. Osteoporos. Int.18(2), 235–243 (2007).
   PubMedGoogle Scholar
• Medici M, van Meurs JB, Rivadeneira F et al.BMP-2 gene polymorphisms and osteoporosis: the Rotterdam Study. J. Bone Miner. Res.21(6), 845–854 (2006).
   PubMed Web of Science ®Google Scholar
• Ichikawa S, Johnson ML, Koller DL et al. Polymorphisms in the bone morphogenetic protein 2 (BMP2) gene do not affect bone mineral density in white men or women. Osteoporos. Int.17(4), 587–592 (2006).
   PubMedGoogle Scholar
• Xiong DH, Shen H, Zhao LJ et al. A robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 Caucasian Nuclear families identified significant association and gene-gene interaction. J. Bone Miner. Res.21(11), 1678–1695 (2006).
   PubMed Web of Science ®Google Scholar
• McGuigan FE, Larzenius E, Callreus M et al. Variation in the BMP2 gene: bone mineral density and ultrasound in young adult and elderly women. Calcif. Tissue Int.81(4), 254–262 (2007).
   PubMed Web of Science ®Google Scholar
• Abrahamsen B, Madsen JS, Tofteng CL et al. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Bone36(3), 577–583 (2005).
   PubMed Web of Science ®Google Scholar
• Riancho JA, Valero C, Zarrabeitia MT. MTHFR polymorphism and bone mineral density: meta-analysis of published studies. Calcif. Tissue Int.79(5), 289–293 (2006).
   PubMedGoogle Scholar
• Hong X, Hsu YH, Terwedow H et al. Association of the methylenetetrahydrofolate reductase C677T polymorphism and fracture risk in Chinese postmenopausal women. Bone40(3), 737–742 (2007).
   PubMedGoogle Scholar
• Liu YJ, Liu XH, Lei SF et al.A2-HS glycoprotein gene is associated with bone size at the hip in Chinese. Yi Chuan Xue Bao32(11), 1128–1135 (2005).
   PubMedGoogle Scholar
• Jiang H, Lei SF, Xiao SM et al. Association and linkage analysis of COL1A1 and AHSG gene polymorphisms with femoral neck bone geometric parameters in both Caucasian and Chinese nuclear families. Acta Pharmacol. Sin.28(3), 375–381 (2007).
   PubMedGoogle Scholar
• Kung AW, Lai BM, Ng MY et al. T-1213C polymorphism of estrogen receptor β is associated with low bone mineral density and osteoporotic fractures. Bone39(5), 1097–1106 (2006).
   PubMedGoogle Scholar
• Silvestri S, Thomsen AB, Gozzini A et al. Estrogen receptor α and β polymorphisms: is there an association with bone mineral density, plasma lipids, and response to postmenopausal hormone therapy? Menopause13(3), 451–461 (2006).
   PubMed Web of Science ®Google Scholar
• Ichikawa S, Koller DL, Peacock M et al. Polymorphisms in the estrogen receptor β (ESR2) gene are associated with bone mineral density in Caucasian men and women. J. Clin. Endocrinol. Metab.90(11), 5921–5927 (2005).
   PubMed Web of Science ®Google Scholar
• Xiao P, Liu PY, Lu Y et al. Association tests of interleukin-6 (IL-6) and type II tumor necrosis factor receptor (TNFR2) genes with bone mineral density in Caucasians using a re-sampling approach. Hum. Genet.117(4), 340–348 (2005).
   PubMedGoogle Scholar
• Lei SF, Liu YZ, Deng FY et al. Association and linkage analyses of interleukin-6 gene 634C/G polymorphism and bone phenotypes in Chinese. J. Bone Miner. Metab.23(4), 323–328 (2005).
   PubMedGoogle Scholar
• Wang YB, Guo JJ, Liu YJ et al. The human calcium-sensing receptor and interleukin-6 genes are associated with bone mineral density in Chinese. Yi Chuan Xue Bao33(10), 870–880 (2006).
   PubMedGoogle Scholar
• Lorentzon M, Swanson C, Eriksson AL et al. Polymorphisms in the aromatase gene predict areal BMD as a result of affected cortical bone size: the GOOD study. J. Bone Miner. Res.21(2), 332–339 (2006).
   PubMed Web of Science ®Google Scholar
• Dick IM, Devine A, Prince RL. Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women. Am. J. Physiol. Endocrinol. Metab.288(5), E989–E995 (2005).
   PubMed Web of Science ®Google Scholar
• Hong X, Hsu YH, Terwedow H et al.CYP19A1 polymorphisms are associated with bone mineral density in Chinese men. Hum. Genet.121(3–4), 491–500 (2007).
   PubMed Web of Science ®Google Scholar
• Arko B, Prezelj J, Kocijancic A et al. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women. Maturitas51(3), 270–279 (2005).
   PubMedGoogle Scholar
• Choi JY, Shin A, Park SK et al. Genetic polymorphisms of OPG, RANK, and ESR1 and bone mineral density in Korean postmenopausal women. Calcif. Tissue Int.77(3), 152–159 (2005).
   PubMed Web of Science ®Google Scholar
• Kim JG, Kim JH, Kim JY et al. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-κB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women. Menopause (2007). (Epub ahead of print).
   Google Scholar
• Koller DL, Ichikawa S, Johnson ML et al. Contribution of the LRP5 gene to normal variation in peak BMD in women. J. Bone Miner. Res.20(1), 75–80 (2005).
   PubMed Web of Science ®Google Scholar
• Bollerslev J, Wilson SG, Dick IM et al.LRP5 gene polymorphisms predict bone mass and incident fractures in elderly Australian women. Bone36(4), 599–606 (2005).
   PubMed Web of Science ®Google Scholar
• van Meurs JB, Rivadeneira F, Jhamai M et al. Common genetic variation of the low-density lipoprotein receptor-related protein 5 and 6 genes determines fracture risk in elderly white men. J. Bone Miner. Res.21(1), 141–150 (2006).
   PubMed Web of Science ®Google Scholar
• Giroux S, Elfassihi L, Cardinal G et al.LRP5 coding polymorphisms influence the variation of peak bone mass in a normal population of French–Canadian women. Bone40(5), 1299–1307 (2007).
   PubMed Web of Science ®Google Scholar
• Xiong DH, Lei SF, Yang F et al. Low-density lipoprotein receptor-related protein 5 (LRP5) gene polymorphisms are associated with bone mass in both Chinese and whites. J. Bone Miner. Res.22(3), 385–393 (2007).
   PubMed Web of Science ®Google Scholar
• Kiel DP, Ferrari SL, Cupples LA et al. Genetic variation at the low-density lipoprotein receptor-related protein 5 (LRP5) locus modulates Wnt signaling and the relationship of physical activity with bone mineral density in men. Bone40(3), 587–596 (2007).
   PubMed Web of Science ®Google Scholar
• Zhao HY, Liu JM, Ning G et al. The influence of Lys3Asn polymorphism in the osteoprotegerin gene on bone mineral density in Chinese postmenopausal women. Osteoporos. Int.16(12), 1519–1524 (2005).
   PubMedGoogle Scholar
• Arko B, Prezelj J, Komel R et al. Sequence variations in the osteoprotegerin gene promoter in patients with postmenopausal osteoporosis. J. Clin. Endocrinol. Metab.87(9), 4080–4084 (2002).
   PubMed Web of Science ®Google Scholar
• Koh JM, Park BL, Kim DJ et al. Identification of novel RANK polymorphisms and their putative association with low BMD among postmenopausal women. Osteoporos. Int.18(3), 323–331 (2007).
   PubMedGoogle Scholar
• Hsu YH, Niu T, Terwedow HA et al. Variation in genes involved in the RANKL/RANK/OPG bone remodeling pathway are associated with bone mineral density at different skeletal sites in men. Hum. Genet.118(5), 568–577 (2006).
   PubMed Web of Science ®Google Scholar
• Daroszewska A, Ralston SH. Genetics of Paget’s disease of bone. Clin. Sci. (Lond.)109(3), 257–263 (2005).
   PubMedGoogle Scholar
• Hughes AE, Ralston SH, Marken J et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat. Genet.24(1), 45–48 (2000).
   PubMed Web of Science ®Google Scholar
• Palenzuela L, Vives-Bauza C, Fernandez-Cadenas I et al. Familial expansile osteolysis in a large Spanish kindred resulting from an insertion mutation in the TNFRSF11A gene. J. Med. Genet.39(10), E67 (2002).
   Google Scholar
• Johnson-Pais TL, Singer FR, Bone HG et al. Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis. J. Bone Miner. Res.18(2), 376–380 (2003).
   PubMed Web of Science ®Google Scholar
• Whyte MP, Hughes AE. Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis. J. Bone Miner. Res.17(1), 26–29 (2002).
   PubMed Web of Science ®Google Scholar
• Streeten EA, McBride DJ, Pollin TI et al. Quantitative trait loci for BMD identified by autosome-wide linkage scan to chromosomes 7q and 21q in men from the Amish Family Osteoporosis Study. J. Bone Miner. Res.21(9), 1433–1442 (2006).
   PubMedGoogle Scholar
• Xiao P, Shen H, Guo YF et al. Genomic regions identified for BMD in a large sample including epistatic interactions and gender-specific effects. J. Bone Miner. Res.21(10), 1536–1544 (2006).
   PubMedGoogle Scholar
• Devoto M, Spotila LD, Stabley DL et al. Univariate and bivariate variance component linkage analysis of a whole-genome scan for loci contributing to bone mineral density. Eur. J. Hum. Genet.13(6), 781–788 (2005).
   PubMedGoogle Scholar
• Cheung CL, Huang QY, Ng MY et al. Confirmation of linkage to chromosome 1q for spine bone mineral density in southern Chinese. Hum. Genet.120(3), 354–359 (2006).
   PubMedGoogle Scholar
• Demissie S, Dupuis J, Cupples LA et al. Proximal hip geometry is linked to several chromosomal regions: genome-wide linkage results from the Framingham Osteoporosis Study. Bone40(3), 743–750 (2007).
   PubMedGoogle Scholar
• Shen H, Long JR, Xiong DH et al. A genomewide scan for quantitative trait loci underlying areal bone size variation in 451 Caucasian families. J. Med. Genet.43(11), 873–880 (2006).
   PubMedGoogle Scholar
• Wang L, Liu YJ, Xiao P et al. Chromosome 2q32 May harbor a QTL affecting BMD variation at different skeletal sites. J. Bone Miner. Res.22(11), 1672–1678 (2007).
   PubMedGoogle Scholar
• Xiong DH, Shen H, Xiao P et al. Genome-wide scan identified QTLs underlying femoral neck cross-sectional geometry that are novel studied risk factors of osteoporosis. J. Bone Miner. Res.21(3), 424–437 (2006).
   PubMedGoogle Scholar
• Ralston SH, Galwey N, MacKay I et al. Loci for regulation of bone mineral density in men and women identified by genome wide linkage scan: the FAMOS study. Hum. Mol. Genet.14(7), 943–951 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang F, Xiao P, Yang F et al. A whole genome linkage scan for QTLs underlying peak bone mineral density. Osteoporos. Int.19(3), 303–310 (2007).
   PubMedGoogle Scholar
• Styrkarsdottir U, Cazier JB, Kong A et al. Linkage of osteoporosis to chromosome 20p12 and association to BMP2. PLoS Biol.1(3), E69 (2003).
   PubMed Web of Science ®Google Scholar
• Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet.6(2), 95–108 (2005).
   PubMed Web of Science ®Google Scholar
• Thomas DC, Haile RW, Duggan D. Recent developments in genomewide association scans: a workshop summary and review. Am. J. Hum. Genet.77(3), 337–345 (2005).
   PubMed Web of Science ®Google Scholar
• Ridker PM, Chasman DI, Zee RY et al. Rationale, design, and methodology of the Women’ Genome Health Study: a genome-wide association study of more than 25 000 initially healthy american women. Clin. Chem.54(2), 249–255 (2007).
   PubMedGoogle Scholar
• Kiel DP, Demissie S, Dupuis J et al. Genome-wide association with bone mass and geometry in the Framingham Heart Study. BMC Med. Genet.8(Suppl. 1), S14 (2007).
   PubMed Web of Science ®Google Scholar
• Tang CH, Hsu TL, Lin WW et al. Attenuation of bone mass and increase of osteoclast formation in decoy receptor 3 transgenic mice. J. Biol. Chem.282(4), 2346–2354 (2007).
   PubMedGoogle Scholar
• Tsukiyama K, Yamada Y, Yamada C et al. Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol. Endocrinol.20(7), 1644–1651 (2006).
   PubMed Web of Science ®Google Scholar
• Sawakami K, Robling AG, Ai M et al. The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment. J. Biol. Chem.281(33), 23698–23711 (2006).
   PubMedGoogle Scholar
• Glocker MO, Guthke R, Kekow J et al. Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med. Res. Rev.26(1), 63–87 (2006).
   PubMed Web of Science ®Google Scholar
• Oertelt S, Selmi C, Invernizzi P et al. Genes and goals: an approach to microarray analysis in autoimmunity. Autoimmun. Rev.4(7), 414–422 (2005).
   PubMed Web of Science ®Google Scholar
• Tampoia M, Brescia V, Fontana A et al. Proteomic: new advances in the diagnosis of rheumatoid arthritis. Clin. Chim. Acta357(2), 219–225 (2005).
   PubMed Web of Science ®Google Scholar
• Shen F, Ruddy MJ, Plamondon P et al. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-α-induced genes in bone cells. J. Leukoc. Biol.77(3), 388–399 (2005).
   PubMed Web of Science ®Google Scholar
• Kalajzic I, Staal A, Yang WP et al. Expression profile of osteoblast lineage at defined stages of differentiation. J. Biol. Chem.280(26), 24618–24626 (2005).
   PubMed Web of Science ®Google Scholar
• Ishida N, Hayashi K, Hattori A et al. CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration. J. Bone Miner. Res.21(1), 48–57 (2006).
   PubMedGoogle Scholar
• Yang M, Mailhot G, MacKay CA et al. Chemokine and chemokine receptor expression during colony stimulating factor-1-induced osteoclast differentiation in the toothless osteopetrotic rat: a key role for CCL9 (MIP-1γ) in osteoclastogenesis in vivo and in vitro.Blood107(6), 2262–2270 (2006).
   PubMed Web of Science ®Google Scholar
• Yang M, Mailhot G, Birnbaum MJ et al. Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis. J. Biol. Chem.281(33), 23598–23605 (2006).
   PubMed Web of Science ®Google Scholar
• Gaasch JA, Bolwahnn AB, Lindsey JS. Hepatocyte growth factor-regulated genes in differentiated RAW 264.7 osteoclast and undifferentiated cells. Gene369, 142–152 (2006).
   PubMedGoogle Scholar
• Meadows NA, Sharma SM, Faulkner GJ et al. The expression of Clcn7 and Ostm1 in osteoclasts is coregulated by microphthalmia transcription factor. J. Biol. Chem.282(3), 1891–1904 (2007).
   PubMedGoogle Scholar
• Liu D, Wise GE. A DNA microarray analysis of chemokine and receptor genes in the rat dental follicle – role of secreted frizzled-related protein-1 in osteoclastogenesis. Bone41(2), 266–272 (2007).
   PubMed Web of Science ®Google Scholar
• Xiao P, Chen Y, Jiang H et al.In vivo Genome-wide expression study on human circulating B cells suggests a novel ESR1 and MAPK3 network for postmenopausal osteoporosis. J. Bone Miner. Res. (2007). (In Press).
   Google Scholar
• Schilling T, Kuffner R, Klein-Hitpass L et al. Microarray analyses of transdifferentiated mesenchymal stem cells. J. Cell. Biochem.103(2), 416–433 (2007).
   Google Scholar
• Beak JY, Kang HS, Kim YS et al. Kruppel-like zinc finger protein Glis3 promotes osteoblast differentiation by regulating FGF18 expression. J. Bone Miner. Res.22(8), 1234–1244 (2007).
   PubMedGoogle Scholar
• Kulterer B, Friedl G, Jandrositz A et al. Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation. BMC Genomics8, 70 (2007).
   PubMed Web of Science ®Google Scholar
• Xiao Y, Fu H, Prasadam I et al. Gene expression profiling of bone marrow stromal cells from juvenile, adult, aged and osteoporotic rats: with an emphasis on osteoporosis. Bone40(3), 700–715 (2007).
   PubMedGoogle Scholar
• Cho JY, Lee WB, Kim HJ et al. Bone-related gene profiles in developing calvaria. Gene372, 71–81 (2006).
   PubMedGoogle Scholar
• Ichikawa T, Horie-Inoue K, Ikeda K et al. Steroid and xenobiotic receptor SXR mediates vitamin K2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J. Biol. Chem.281(25), 16927–16934 (2006).
   PubMedGoogle Scholar
• Pochampally RR, Ylostalo J, Penfornis P et al. Histamine receptor h1 and dermatopontin: new downstream targets of the vitamin d receptor. J. Bone Miner. Res.22(9), 1338–1349 (2007).
   PubMedGoogle Scholar
• Reppe S, Stilgren L, Olstad OK et al. Gene expression profiles give insight into the molecular pathology of bone in primary hyperparathyroidism. Bone39(1), 189–198 (2006).
   PubMedGoogle Scholar
• Onyia JE, Helvering LM, Gelbert L et al. Molecular profile of catabolic versus anabolic treatment regimens of parathyroid hormone (PTH) in rat bone: an analysis by DNA microarray. J. Cell. Biochem.95(2), 403–418 (2005).
   PubMedGoogle Scholar
• Ducy P, Amling M, Takeda S et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell100(2), 197–207 (2000).
   PubMed Web of Science ®Google Scholar
• Lee NK, Sowa H, Hinoi E et al. Endocrine regulation of energy metabolism by the skeleton. Cell130(3), 456–469 (2007).
   PubMed Web of Science ®Google Scholar
• Kindblom JM, Gevers EF, Skrtic SM et al. Increased adipogenesis in bone marrow but decreased bone mineral density in mice devoid of thyroid hormone receptors. Bone36(4), 607–616 (2005).
   PubMed Web of Science ®Google Scholar
• Lu NZ, Collins JB, Grissom SF et al. Selective regulation of bone cell apoptosis by translational isoforms of the glucocorticoid receptor. Mol. Cell. Biol.27(20), 7143–7160 (2007).
   PubMed Web of Science ®Google Scholar
• Miki Y, Suzuki T, Hatori M et al. Effects of aromatase inhibitors on human osteoblast and osteoblast-like cells: a possible androgenic bone protective effects induced by exemestane. Bone40(4), 876–887 (2007).
   PubMed Web of Science ®Google Scholar
• Govoni KE, Lee SK, Chadwick RB et al. Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation. Am. J. Physiol. Endocrinol. Metab.291(1), E128–E136 (2006).
   PubMedGoogle Scholar
• Little RD, Carulli JP, Del Mastro RG et al. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait. Am. J. Hum. Genet.70(1), 11–19 (2002).
   PubMed Web of Science ®Google Scholar
• Vaes BL, Dechering KJ, van Someren EP et al. Microarray analysis reveals expression regulation of Wnt antagonists in differentiating osteoblasts. Bone36(5), 803–811 (2005).
   PubMedGoogle Scholar
• Lau KH, Kapur S, Kesavan C et al. Up-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in C57BL/6J osteoblasts as opposed to C3H/HeJ osteoblasts in part contributes to the differential anabolic response to fluid shear. J. Biol. Chem.281(14), 9576–9588 (2006).
   PubMed Web of Science ®Google Scholar
• Clines GA, Mohammad KS, Bao Y et al. Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation. Mol. Endocrinol.21(2), 486–498 (2007).
   PubMed Web of Science ®Google Scholar
• Patel MJ, Liu W, Sykes MC et al. Identification of mechanosensitive genes in osteoblasts by comparative microarray studies using the rotating wall vessel and the random positioning machine. J. Cell. Biochem.101(3), 587–599 (2007).
   PubMed Web of Science ®Google Scholar
• Pardo SJ, Patel MJ, Sykes MC et al. Simulated microgravity using the Random Positioning Machine inhibits differentiation and alters gene expression profiles of 2T3 preosteoblasts. Am. J. Physiol. Cell Physiol.288(6), C1211–C1221 (2005).
   PubMed Web of Science ®Google Scholar
• Lee YH, Nahm DS, Jung YK et al. Differential gene expression of periodontal ligament cells after loading of static compressive force. J. Periodontol.78(3), 446–452 (2007).
   PubMed Web of Science ®Google Scholar
• James MJ, Jarvinen E, Wang XP et al. Different roles of Runx2 during early neural crest-derived bone and tooth development. J. Bone Miner. Res.21(7), 1034–1044 (2006).
   PubMed Web of Science ®Google Scholar
• Ishijima M, Ezura Y, Tsuji K et al. Osteopontin is associated with nuclear factor kB gene expression during tail-suspension-induced bone loss. Exp. Cell Res.312(16), 3075–3083 (2006).
   PubMed Web of Science ®Google Scholar
• Aalami OO, Nacamuli RP, Salim A et al. Differential transcriptional expression profiles of juvenile and adult calvarial bone. Plast. Reconstr. Surg.115(7), 1986–1994 (2005).
   PubMedGoogle Scholar
• Komatsu DE, Bosch-Marce M, Semenza GL et al. Enhanced bone regeneration associated with decreased apoptosis in mice with partial HIF-1a deficiency. J. Bone Miner. Res.22(3), 366–374 (2007).
   PubMed Web of Science ®Google Scholar
• Fang TD, Salim A, Xia W et al. Angiogenesis is required for successful bone induction during distraction osteogenesis. J. Bone Miner. Res.20(7), 1114–1124 (2005).
   PubMed Web of Science ®Google Scholar
• Li X, Wang H, Touma E, Rousseau E, Quigg RJ, Ryaby JT. Genetic network and pathway analysis of differentially expressed proteins during critical cellular events in fracture repair. J. Cell. Biochem.100(2), 527–543 (2007).
   PubMed Web of Science ®Google Scholar
• Nacamuli RP, Fong KD, Lenton KA et al. Expression and possible mechanisms of regulation of BMP3 in rat cranial sutures. Plast. Reconstr. Surg.116(5), 1353–1362 (2005).
   PubMedGoogle Scholar
• Narita Y, Nomura J, Ohta S et al. Royal jelly stimulates bone formation: physiologic and nutrigenomic studies with mice and cell lines. Biosci. Biotechnol. Biochem.70(10), 2508–2514 (2006).
   PubMed Web of Science ®Google Scholar
• Pie JE, Park JH, Park YH et al. Effect of genistein on the expression of bone metabolism genes in ovariectomized mice using a cDNA microarray. J. Nutr. Biochem.17(3), 157–164 (2006).
   PubMedGoogle Scholar
• Rundle CH, Wang H, Yu H et al. Microarray analysis of gene expression during the inflammation and endochondral bone formation stages of rat femur fracture repair. Bone38(4), 521–529 (2006).
   PubMedGoogle Scholar
• Niikura T, Hak DJ, Reddi AH. Global gene profiling reveals a downregulation of BMP gene expression in experimental atrophic nonunions compared to standard healing fractures. J. Orthop. Res.24(7), 1463–1471 (2006).
   PubMed Web of Science ®Google Scholar
• Ganno T, Yamada S, Ohara N et al. Early gene expression analyzed by cDNA microarray and real-time PCR in osteoblasts cultured with chitosan monomer. J. Biomed. Mater. Res. A82(1), 188–194 (2007).
   PubMedGoogle Scholar
• Sollazzo V, Palmieri A, Pezzetti F et al. Genetic effect of anatase on osteoblast-like cells. J. Biomed. Mater. Res. B Appl. Biomater. DOI: 10.1002/jbm.b.30912 (2007) (Epub ahead of print).
   Google Scholar
• Ikeda R, Yoshida K, Tsukahara S et al. The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1. J. Biol. Chem.280(9), 8523–8530 (2005).
   PubMedGoogle Scholar
• Inoue I, Ikeda R, Tsukahara S. Current topics in pharmacological research on bone metabolism: promyelotic leukemia zinc finger (PLZF) and tumor necrosis factor-a-stimulated gene 6 (TSG-6) identified by gene expression analysis play roles in the pathogenesis of ossification of the posterior longitudinal ligament. J. Pharmacol. Sci.100(3), 205–210 (2006).
   PubMedGoogle Scholar
• Naot D, Bava U, Matthews B et al. Differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget’s disease of bone. J. Bone Miner. Res.22(2), 298–309 (2007).
   PubMed Web of Science ®Google Scholar
• Carinci F, Palmieri A, Perrotti V et al. Genetic effects of Medpor on osteoblast-like cells. J. Craniofac. Surg.17(6), 1243–1250 (2006).
   PubMedGoogle Scholar
• Centola M, Frank MB, Bolstad AI et al. Genome-scale assessment of molecular pathology in systemic autoimmune diseases using microarray technology: a potential breakthrough diagnostic and individualized therapy-design tool. Scand. J. Immunol.64(3), 236–242 (2006).
   PubMedGoogle Scholar
• Brennan F, Beech J. Update on cytokines in rheumatoid arthritis. Curr. Opin. Rheumatol.19(3), 296–301 (2007).
   PubMed Web of Science ®Google Scholar
• Abbott A. A post-genomic challenge: learning to read patterns of protein synthesis. Nature402(6763), 715–720 (1999).
   PubMedGoogle Scholar
• Anderson L, Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis18(3–4), 533–537 (1997).
   PubMed Web of Science ®Google Scholar
• Gygi SP, Rochon Y, Franza BR et al. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol.19(3), 1720–1730 (1999).
   PubMed Web of Science ®Google Scholar
• Ward DF Jr, Salasznyk RM, Klees RF et al. Mechanical strain enhances extracellular matrix-induced gene focusing and promotes osteogenic differentiation of human mesenchymal stem cells through an extracellular-related kinase-dependent pathway. Stem Cells Dev.16(3), 467–480 (2007).
   PubMedGoogle Scholar
• Kadri T, Lataillade JJ, Doucet C et al. Proteomic study of galectin-1 expression in human mesenchymal stem cells. Stem Cells Dev.14(2), 204–212 (2005).
   PubMed Web of Science ®Google Scholar
• Salasznyk RM, Westcott AM, Klees RF et al. Comparing the protein expression profiles of human mesenchymal stem cells and human osteoblasts using gene ontologies. Stem Cells Dev.14(4), 354–366 (2005).
   PubMed Web of Science ®Google Scholar
• Kratchmarova I, Blagoev B, Haack-Sorensen M et al. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science308(5727), 1472–1477 (2005).
   PubMed Web of Science ®Google Scholar
• Sun HJ, Bahk YY, Choi YR et al. A proteomic analysis during serial subculture and osteogenic differentiation of human mesenchymal stem cell. J. Orthop. Res.24(11), 2059–2071 (2006).
   PubMed Web of Science ®Google Scholar
• Ye NS, Chen J, Luo GA et al. Proteomic profiling of rat bone marrow mesenchymal stem cells induced by 5-azacytidine. Stem Cells Dev.15(5), 665–676 (2006).
   PubMed Web of Science ®Google Scholar
• Ryu J, Kim H, Lee SK et al. Proteomic identification of the TRAF6 regulation of vacuolar ATPase for osteoclast function. Proteomics5(16), 4152–4160 (2005).
   PubMed Web of Science ®Google Scholar
• Xiao Z, Camalier CE, Nagashima K et al. Analysis of the extracellular matrix vesicle proteome in mineralizing osteoblasts. J. Cell. Physiol.210(2), 325–335 (2007).
   PubMed Web of Science ®Google Scholar
• Czupalla C, Mansukoski H, Riedl T et al. Proteomic analysis of lysosomal acid hydrolases secreted by osteoclasts: implications for lytic enzyme transport and bone metabolism. Mol. Cell. Proteomics5(1), 134–143 (2006).
   PubMedGoogle Scholar
• Spreafico A, Frediani B, Capperucci C et al. A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics6(12), 3520–3532 (2006).
   PubMed Web of Science ®Google Scholar
• Liu XD, Zeng BF, Xu JG et al. Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation. Proteomics6(3), 1019–1028 (2006).
   PubMed Web of Science ®Google Scholar
• Tan X, Cai D, Wu Y et al. Comparative analysis of serum proteomes: discovery of proteins associated with osteonecrosis of the femoral head. Transl. Res.148(3), 114–119 (2006).
   PubMed Web of Science ®Google Scholar
• Noben JP, Dumont D, Kwasnikowska N et al. Lumbar cerebrospinal fluid proteome in multiple sclerosis: characterization by ultrafiltration, liquid chromatography, and mass spectrometry. J. Proteome Res.5(7), 1647–1657 (2006).
   PubMed Web of Science ®Google Scholar
• Scuderi GJ, Brusovanik GV, Anderson DG et al. Cytokine assay of the epidural space lavage in patients with lumbar intervertebral disk herniation and radiculopathy. J. Spinal Disord. Tech.19(4), 266–269 (2006).
   PubMedGoogle Scholar
• Lee WY, Rhee EJ, Oh KW et al. Identification of adiponectin and its receptors in human osteoblast-like cells and association of T45G polymorphism in exon 2 of adiponectin gene with lumbar spine bone mineral density in Korean women. Clin. Endocrinol. (Oxford)65(5), 631–637 (2006).
   PubMedGoogle Scholar
• Wang CY, Nguyen ND, Morrison NA et al. B3-adrenergic receptor gene, body mass index, bone mineral density and fracture risk in elderly men and women: the Dubbo Osteoporosis Epidemiology Study (DOES). BMC Med. Genet.7, 57 (2006).
   PubMedGoogle Scholar
• Lei SF, Zhang YY, Deng FY et al. Bone mineral density and five prominent candidate genes in Chinese men: associations, interaction effects and their implications. Maturitas51(2), 199–206 (2005).
   PubMedGoogle Scholar
• Yang YJ, Wang YB, Lei SF et al. AHSG gene polymorphisms are associated with bone mineral density in Caucasian nuclear families. Eur. J. Epidemiol.22(8), 527–532 (2007).
   PubMedGoogle Scholar
• Deng FY, Long JR, Lei SF et al. Potential effect of inter-genic action on peak bone mass (PBM) in Chinese females. Yi Chuan Xue Bao32(10), 1003–1010 (2005).
   PubMedGoogle Scholar
• Yamada Y, Ando F, Shimokata H. Association of candidate gene polymorphisms with bone mineral density in community-dwelling Japanese women and men. Int. J. Mol. Med.19(5), 791–801 (2007).
   PubMedGoogle Scholar
• Yamaguchi J, Hasegawa Y, Kawasaki M et al. ALDH2 polymorphisms and bone mineral density in an elderly Japanese population. Osteoporos. Int.17(6), 908–913 (2006).
   PubMedGoogle Scholar
• Foroud T, Ichikawa S, Koller D et al. Association studies of ALOX5 and bone mineral density in healthy adults. Osteoporos. Int. DOI: 10.1007/s00198-007-0484-z (2007) (Epub ahead of print).
   PubMedGoogle Scholar
• Ichikawa S, Koller DL, Johnson ML et al. Human ALOX12, but not ALOX15, is associated with BMD in white men and women. J. Bone Miner. Res.21(4), 556–564 (2006).
   PubMed Web of Science ®Google Scholar
• Mullin BH, Spector TD, Curtis CC et al. Polymorphisms in ALOX12, but not ALOX15, are significantly associated with BMD in postmenopausal women. Calcif. Tissue Int.81(1), 10–17 (2007).
   PubMedGoogle Scholar
• Urano T, Shiraki M, Fujita M et al. Association of a single nucleotide polymorphism in the lipoxygenase ALOX15 5´-flanking region (-5229G/A) with bone mineral density. J. Bone Miner. Metab.23(3), 226–230 (2005).
   PubMed Web of Science ®Google Scholar
• Cheung CL, Chan V, Kung AW. A differential association of ALOX15 polymorphisms with bone mineral density in pre- and post-menopausal women. Hum. Hered.65(1), 1–8 (2008).
   PubMed Web of Science ®Google Scholar
• Wong SY, Lau EM, Li M et al. The prevalence of Apo E4 genotype and its relationship to bone mineral density in Hong Kong Chinese. J. Bone Miner. Metab.23(3), 261–265 (2005).
   PubMedGoogle Scholar
• Valimaki VV, Piippo K, Valimaki S et al. The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men. Osteoporos. Int.16(12), 1633–1640 (2005).
   PubMedGoogle Scholar
• Yamada Y, Ando F, Niino N et al. Association of polymorphisms of the androgen receptor and klotho genes with bone mineral density in Japanese women. J. Mol. Med.83(1), 50–57 (2005).
   PubMedGoogle Scholar
• Kenny AM, McGee D, Joseph C et al. Lack of association between androgen receptor polymorphisms and bone mineral density or physical function in older men. Endocr. Res.31(4), 285–293 (2005).
   PubMed Web of Science ®Google Scholar
• Retornaz F, Paris F, Lumbroso S et al. Association between androgen receptor gene polymorphism and bone density in older women using hormone replacement therapy. Maturitas55(4), 325–333 (2006).
   PubMedGoogle Scholar
• Jiang DK, Xu FH, Liu MY et al. No evidence of association of the osteocalcin gene HindIII polymorphism with bone mineral density in Chinese women. J. Musculoskelet. Neuronal Interact.7(2), 149–154 (2007).
   PubMedGoogle Scholar
• Ramesh BL, Wilson SG, Dick IM et al. Bone mass effects of a BMP4 gene polymorphism in postmenopausal women. Bone36(3), 555–561 (2005).
   PubMedGoogle Scholar
• Oh B, Kim SY, Kim DJ et al. Associations of catalase gene polymorphisms with bone mineral density and bone turnover markers in postmenopausal women. J. Med. Genet.44(1), E62 (2007).
   Google Scholar
• Drummond FJ, Mackrill JJ, O’Sullivan K et al. CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss. J. Bone Miner. Metab.24(1), 28–35 (2006).
   PubMedGoogle Scholar
• Kornak U, Ostertag A, Branger S et al. Polymorphisms in the CLCN7 gene modulate bone density in postmenopausal women and in patients with autosomal dominant osteopetrosis type II. J. Clin. Endocrinol. Metab.91(3), 995–1000 (2006).
   PubMedGoogle Scholar
• Pettersson U, Albagha OM, Mirolo M et al. Polymorphisms of the CLCN7 gene are associated with BMD in women. J. Bone Miner. Res.20(11), 1960–1967 (2005).
   PubMedGoogle Scholar
• Karsak M, Cohen-Solal M, Freudenberg J et al. Cannabinoid receptor type 2 gene is associated with human osteoporosis. Hum. Mol. Genet.14(22), 3389–3396 (2005).
   PubMed Web of Science ®Google Scholar
• Stewart TL, Jin H, McGuigan FE et al. Haplotypes defined by promoter and intron 1 polymorphisms of the COLIA1 gene regulate bone mineral density in women. J. Clin. Endocrinol. Metab.91(9), 3575–3583 (2006).
   PubMed Web of Science ®Google Scholar
• Nguyen TV, Esteban LM, White CP et al. Contribution of the collagen I α1 and vitamin D receptor genes to the risk of hip fracture in elderly women. J. Clin. Endocrinol. Metab.90(12), 6575–6579 (2005).
   PubMed Web of Science ®Google Scholar
• Todhunter CE, Sutherland-Craggs A, Bartram SA et al. Influence of IL-6, COL1A1, and VDR gene polymorphisms on bone mineral density in Crohn’s disease. Gut54(11), 1579–1584 (2005).
   PubMedGoogle Scholar
• Bandres E, Pombo I, Gonzalez-Huarriz M et al. Association between bone mineral density and polymorphisms of the VDR, ERα, COL1A1 and CTR genes in Spanish postmenopausal women. J. Endocrinol. Invest.28(4), 312–321 (2005).
   PubMedGoogle Scholar
• Stewart TL, Roschger P, Misof BM et al. Association of COLIA1 Sp1 alleles with defective bone nodule formation in vitro and abnormal bone mineralization in vivo. Calcif. Tissue Int.77(2), 113–118 (2005).
   PubMedGoogle Scholar
• Weichetova M, Stepan JJ, Haas T et al. The risk of Colles’ fracture is associated with the collagen I α1 Sp1 polymorphism and ultrasound transmission velocity in the calcaneus only in heavier postmenopausal women. Calcif. Tissue Int.76(2), 98–106 (2005).
   PubMedGoogle Scholar
• Lei SF, Deng FY, Xiao SM et al. Association and haplotype analyses of the COL1A2 and ER-α gene polymorphisms with bone size and height in Chinese. Bone36(3), 533–541 (2005).
   PubMedGoogle Scholar
• Lei SF, Deng FY, Dvornyk V et al. The (GT)n polymorphism and haplotype of the COL1A2 gene, but not the (AAAG)n polymorphism of the PTHR1 gene, are associated with bone mineral density in Chinese. Hum. Genet.116(3), 200–207 (2005).
   PubMedGoogle Scholar
• Stolk L, van Meurs JB, Jhamai M et al. The catechol-O-methyltransferase Met158 low-activity allele and association with nonvertebral fracture risk in elderly men. J. Clin. Endocrinol. Metab.92(8), 3206–3212 (2007).
   PubMed Web of Science ®Google Scholar
• Lorentzon M, Eriksson AL, Nilsson S et al. Association between physical activity and BMD in young men is modulated by catechol-O-methyltransferase (COMT) genotype: the GOOD study. J. Bone Miner. Res.22(8), 1165–1172 (2007).
   PubMedGoogle Scholar
• Magana JJ, Gomez R, Cisneros B et al. Association of the CT gene (CA) polymorphism with BMD in osteoporotic Mexican women. Clin. Genet.70(5), 402–408 (2006).
   PubMedGoogle Scholar
• Chen HY, Chen WC, Hsu CM et al. Tumor necrosis factor α, CYP 17, urokinase, and interleukin 10 gene polymorphisms in postmenopausal women: correlation to bone mineral density and susceptibility to osteoporosis. Eur. J. Obstet. Gynecol. Reprod. Biol.122(1), 73–78 (2005).
   PubMedGoogle Scholar
• Yamada Y, Ando F, Shimokata H. Association of polymorphisms in CYP17A1, MTP, and VLDLR with bone mineral density in community-dwelling Japanese women and men. Genomics86(1), 76–85 (2005).
   PubMedGoogle Scholar
• Enjuanes A, Garcia-Giralt N, Supervia A et al. A new SNP in a negative regulatory region of the CYP19A1 gene is associated with lumbar spine BMD in postmenopausal women. Bone38(5), 738–743 (2006).
   PubMed Web of Science ®Google Scholar
• Riancho JA, Zarrabeitia MT, Valero C et al. Aromatase gene and osteoporosis: relationship of ten polymorphic loci with bone mineral density. Bone36(5), 917–925 (2005).
   PubMed Web of Science ®Google Scholar
• Kastelan D, Grubic Z, Kraljevic I et al. Decreased peak bone mass is associated with a 3-bp deletion/insertion of the CYP19 intron 4 polymorphism: preliminary data from the GOOS study. J. Endocrinol. Invest.30(6), 465–469 (2007).
   PubMed Web of Science ®Google Scholar
• Napoli N, Villareal DT, Mumm S et al. Effect of CYP1A1 gene polymorphisms on estrogen metabolism and bone density. J. Bone Miner. Res.20(2), 232–239 (2005).
   PubMed Web of Science ®Google Scholar
• Bacsi K, Kosa JP, Borgulya G et al.CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women. Calcif. Tissue Int.80(3), 154–159 (2007).
   PubMed Web of Science ®Google Scholar
• Ongphiphadhanakul B, Chanprasertyothin S, Saetung S et al. A specific haplotype in the 3´ end of estrogen-receptor α gene is associated with low bone mineral density in premenopausal women and increased risk of postmenopausal osteoporosis. Osteoporos. Int.16(10), 1233–1238 (2005).
   PubMedGoogle Scholar
• Dennison E, Syddall H, Fall C et al. Evidence of sexual dimorphism in relationships between estrogen receptor polymorphisms and bone mass: the Hertfordshire study. J. Rheumatol.32(12), 2400–2404 (2005).
   PubMedGoogle Scholar
• Nam HS, Shin MH, Kweon SS et al. Association of estrogen receptor-α gene polymorphisms with bone mineral density in postmenopausal Korean women. J. Bone Miner. Metab.23(1), 84–89 (2005).
   PubMed Web of Science ®Google Scholar
• Jian WX, Yang YJ, Long JR et al. Estrogen receptor α gene relationship with peak bone mass and body mass index in Chinese nuclear families. J. Hum. Genet.50(9), 477–482 (2005).
   PubMedGoogle Scholar
• Yahata T, Quan J, Tamura N et al. Association between single nucleotide polymorphisms of estrogen receptor a gene and efficacy of HRT on bone mineral density in post-menopausal Japanese women. Hum. Reprod.20(7), 1860–1866 (2005).
   PubMedGoogle Scholar
• Yim CH, Choi JT, Choi HA et al. Association of estrogen receptor α gene microsatellite polymorphism with annual changes in bone mineral density in Korean women with hormone replacement therapy. J. Bone Miner. Metab.23(5), 395–400 (2005).
   PubMedGoogle Scholar
• Binh TQ, Shinka T, Khan NC et al. Association of estrogen receptor a gene polymorphisms and lifestyle factors with calcaneal quantitative ultrasound and osteoporosis in postmenopausal Vietnamese women. J. Hum. Genet.51(11), 1022–1029 (2006).
   PubMedGoogle Scholar
• Cusack S, Molgaard C, Michaelsen KF et al. Vitamin D and estrogen receptor-a genotype and indices of bone mass and bone turnover in Danish girls. J. Bone Miner. Metab.24(4), 329–336 (2006).
   PubMed Web of Science ®Google Scholar
• Lau HH, Ng MY, Cheung WM et al. Assessment of linkage and association of 13 genetic loci with bone mineral density. J. Bone Miner. Metab.24(3), 226–234 (2006).
   PubMedGoogle Scholar
• Cepollaro C, Lauretani F, Gozzini A et al. Relationship of volumetric bone mineral density and structural parameters with ERα gene polymorphisms. Calcif. Tissue Int.80(5), 307–315 (2007).
   PubMedGoogle Scholar
• Ivanova JT, Doukova PB, Boyanov MA et al. PvuII and XbaI polymorphisms of the estrogen receptor gene and bone mineral density in a Bulgarian population sample. Hormones (Athens)6(1), 36–43 (2007).
   PubMedGoogle Scholar
• Valero C, Zarrabeitia MT, Hernandez JL et al. Bone mass in young adults: relationship with gender, weight and genetic factors. J. Intern. Med.258(6), 554–562 (2005).
   PubMed Web of Science ®Google Scholar
• Moron FJ, Mendoza N, Vazquez F et al. Multilocus analysis of estrogen-related genes in Spanish postmenopausal women suggests an interactive role of ESR1, ESR2 and NRIP1 genes in the pathogenesis of osteoporosis. Bone39(1), 213–221 (2006).
   PubMed Web of Science ®Google Scholar
• Laflamme N, Giroux S, Loredo-Osti JC et al. A frequent regulatory variant of the estrogen-related receptor α gene associated with BMD in French–Canadian premenopausal women. J. Bone Miner. Res.20(6), 938–944 (2005).
   PubMedGoogle Scholar
• Koh JM, Oh B, Lee JY et al. Association of FLT3 polymorphisms with low BMD and risk of osteoporotic fracture in postmenopausal women. J. Bone Miner. Res.22(11), 1752–1758 (2007).
   PubMedGoogle Scholar
• Yamada Y, Ando F, Shimokata H. Association of polymorphisms in forkhead box C2 and perilipin genes with bone mineral density in community-dwelling Japanese individuals. Int. J. Mol. Med.18(1), 119–127 (2006).
   PubMedGoogle Scholar
• Lories RJ, Boonen S, Peeters J et al. Evidence for a differential association of the Arg200Trp single-nucleotide polymorphism in FRZB with hip osteoarthritis and osteoporosis. Rheumatology (Oxford)45(1), 113–114 (2006).
   PubMedGoogle Scholar
• Kinoshita H, Nakagawa K, Narusawa K et al. A functional single nucleotide polymorphism in the vitamin-K-dependent γ-glutamyl carboxylase gene (Arg325Gln) is associated with bone mineral density in elderly Japanese women. Bone40(2), 451–456 (2007).
   PubMed Web of Science ®Google Scholar
• Kenth G, Shao Z, Cole DE et al. Relationship of the human growth hormone receptor exon 3 genotype with final adult height and bone mineral density. J. Clin. Endocrinol. Metab.92(2), 725–728 (2007).
   PubMedGoogle Scholar
• Douroudis K, Tarassi K, Athanassiades T et al. HLA alleles as predisposal factors for postmenopausal osteoporosis in a Greek population. Tissue Antigens69(6), 592–596 (2007).
   PubMedGoogle Scholar
• Jiang DK, Shen H, Li MX et al. No major effect of the insulin-like growth factor I gene on bone mineral density in premenopausal Chinese women. Bone36(4), 694–699 (2005).
   PubMedGoogle Scholar
• Kim SY, Lee JY, Kim HY et al. Association of KIT gene polymorphisms with bone mineral density in postmenopausal Korean women. J. Hum. Genet.52(6), 502–509 (2007).
   PubMedGoogle Scholar
• Mullin BH, Wilson SG, Islam FM et al.Klotho gene polymorphisms are associated with osteocalcin levels but not bone density of aged postmenopausal women. Calcif. Tissue Int.77(3), 145–151 (2005).
   PubMed Web of Science ®Google Scholar
• Riancho JA, Valero C, Hernandez JL et al. Association of the F352V variant of the Klotho gene with bone mineral density. Biogerontology8(2), 121–127 (2006).
   PubMedGoogle Scholar
• Fairbrother UL, Tanko LB, Walley AJ et al. Leptin receptor genotype at Gln223Arg is associated with body composition, BMD, and vertebral fracture in postmenopausal Danish women. J. Bone Miner. Res.22(4), 544–550 (2007).
   PubMedGoogle Scholar
• Ferrari SL, Deutsch S, Baudoin C et al. LRP5 gene polymorphisms and idiopathic osteoporosis in men. Bone37(6), 770–775 (2005).
   PubMedGoogle Scholar
• Zhang ZL, Qin YJ, He JW et al. Association of polymorphisms in low-density lipoprotein receptor-related protein 5 gene with bone mineral density in postmenopausal Chinese women. Acta Pharmacol. Sin.26(9), 1111–1116 (2005).
   PubMedGoogle Scholar
• Koay MA, Tobias JH, Leary SD et al. The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood. Calcif. Tissue Int.81(1), 1–9 (2007).
   PubMed Web of Science ®Google Scholar
• Ezura Y, Nakajima T, Urano T et al. Association of a single-nucleotide variation (A1330V) in the low-density lipoprotein receptor-related protein 5 gene (LRP5) with bone mineral density in adult Japanese women. Bone40(4), 997–1005 (2007).
   PubMed Web of Science ®Google Scholar
• Saarinen A, Valimaki VV, Valimaki MJ et al. The A1330V polymorphism of the low-density lipoprotein receptor-related protein 5 gene (LRP5) associates with low peak bone mass in young healthy men. Bone40(4), 1006–1012 (2007).
   PubMed Web of Science ®Google Scholar
• Li Y, Sun CH, Yin H et al. Association of polymorphism of low density lipoprotein receptor-related protein 5 Q89R, A1330V with bone mineral density in premenopausal northern Chinese women. Wei Sheng Yan Jiu35(5), 576–579 (2006).
   PubMedGoogle Scholar
• Zhang ZL, He JW, Qin YJ et al. Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families. Osteoporos. Int.19(1), 39–47 (2007).
   PubMedGoogle Scholar
• Valero C, Alonso MA, Zarrabeitia MT et al.MTHFR C677T polymorphism and osteoporotic fractures. Horm. Metab. Res.39(8), 543–547 (2007).
   PubMedGoogle Scholar
• Baines M, Kredan MB, Usher J et al. The association of homocysteine and its determinants MTHFR genotype, folate, vitamin B12 and vitamin B6 with bone mineral density in postmenopausal British women. Bone40(3), 730–736 (2007).
   PubMed Web of Science ®Google Scholar
• Taylor BC, Schreiner PJ, Zmuda JM et al. Association of endothelial nitric oxide synthase genotypes with bone mineral density, bone loss, hip structure, and risk of fracture in older women: the SOF study. Bone39(1), 174–180 (2006).
   PubMedGoogle Scholar
• Vidal C, Brincat M, Xuereb AA. TNFRSF11B gene variants and bone mineral density in postmenopausal women in Malta. Maturitas53(4), 386–395 (2006).
   PubMedGoogle Scholar
• Kim GS, Koh JM, Chang JS et al. Association of the OSCAR promoter polymorphism with BMD in postmenopausal women. J. Bone Miner. Res.20(8), 1342–1348 (2005).
   PubMed Web of Science ®Google Scholar
• Ohlendorff SD, Tofteng CL, Jensen JE et al. Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet. Genomics17(7), 555–567 (2007).
   PubMed Web of Science ®Google Scholar
• Reneland RH, Mah S, Kammerer S et al. Association between a variation in the phosphodiesterase 4D gene and bone mineral density. BMC Med. Genet.6, 9 (2005).
   PubMedGoogle Scholar
• Tasker PN, Macdonald H, Fraser WD et al. Association of PLOD1 polymorphisms with bone mineral density in a population-based study of women from the UK. Osteoporos. Int.17(7), 1078–1085 (2006).
   PubMedGoogle Scholar
• Hwang JY, Lee JY, Park MH et al. Association of PLXNA2 polymorphisms with vertebral fracture risk and bone mineral density in postmenopausal Korean population. Osteoporos. Int.17(11), 1592–1601 (2006).
   PubMedGoogle Scholar
• Sudo Y, Ezura Y, Kajita M et al. Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women. J. Hum. Genet.50(5), 235–240 (2005).
   PubMedGoogle Scholar
• Rhee EJ, Oh KW, Lee WY et al. The effects of C161–>T polymorphisms in exon 6 of peroxisome proliferator-activated receptor-g gene on bone mineral metabolism and serum osteoprotegerin levels in healthy middle-aged women. Am. J. Obstet. Gynecol.192(4), 1087–1093 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang ZL, He JW, Qin YJ et al. Association between SNP and haplotypes in PPARGC1 and adiponectin genes and bone mineral density in Chinese nuclear families. Acta Pharmacol. Sin.28(2), 287–295 (2007).
   PubMedGoogle Scholar
• Liu PY, Zhang YY, Lu Y et al. A survey of haplotype variants at several disease candidate genes: the importance of rare variants for complex diseases. J. Med. Genet.42(3), 221–227 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang YY, Liu PY, Lu Y et al. Tests of linkage and association of PTH/PTHrP receptor type 1 gene with bone mineral density and height in Caucasians. J. Bone Miner. Metab.24(1), 36–41 (2006).
   PubMedGoogle Scholar
• Vilarino-Guell C, Miles LJ, Duncan EL et al.PTHR1 polymorphisms influence BMD variation through effects on the growing skeleton. Calcif. Tissue Int.81(4), 270–278 (2007).
   PubMedGoogle Scholar
• Huang QY, Kung AW. The association of common polymorphisms in the QPCT gene with bone mineral density in the Chinese population. J. Hum. Genet.52(9), 757–762 (2007).
   PubMedGoogle Scholar
• Mencej S, Prezelj J, Kocijancic A et al. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women. Maturitas55(3), 219–226 (2006).
   PubMed Web of Science ®Google Scholar
• Ermakov S, Malkin I, Keter M et al. Family-based association study of ROR2 polymorphisms with an array of radiographic hand bone strength phenotypes. Osteoporos. Int.18(12), 1683–1692 (2007).
   PubMedGoogle Scholar
• Bustamante M, Nogues X, Agueda L et al. Promoter 2 -1025 T/C polymorphism in the RUNX2 gene is associated with femoral neck BMD in Spanish postmenopausal women. Calcif. Tissue Int.81(4), 327–332 (2007).
   PubMedGoogle Scholar
• Lee SA, Choi JY, Shin CS et al.SULT1E1 genetic polymorphisms modified the association between phytoestrogen consumption and bone mineral density in healthy Korean women. Calcif. Tissue Int.79(3), 152–159 (2006).
   PubMedGoogle Scholar
• Huang QY, Shen H, Deng HY et al. CA repeat polymorphism of the TNFR2 gene is not associated with bone mineral density in two independent Caucasian populations. J. Bone Miner. Metab.24(2), 132–137 (2006).
   PubMedGoogle Scholar
• Goseki-Sone M, Sogabe N, Fukushi-Irie M et al. Functional analysis of the single nucleotide polymorphism (787T>C) in the tissue-nonspecific alkaline phosphatase gene associated with BMD. J. Bone Miner. Res.20(5), 773–782 (2005).
   PubMedGoogle Scholar
• Ivanova J, Doukova P, Boyanov M et al. FokI and BsmI polymorphisms of the vitamin D receptor gene and bone mineral density in a random Bulgarian population sample. Endocrine29(3), 413–418 (2006).
   PubMedGoogle Scholar
• Gentil P, Lima RM, Lins TC et al. Physical activity, Cdx-2 genotype, and BMD. Int. J. Sports Med.28(12), 151–162 (2007).
   Google Scholar
• Fang Y, van Meurs JB, Rivadeneira F et al. Vitamin D receptor gene haplotype is associated with body height and bone size. J. Clin. Endocrinol. Metab.92(4), 1491–1501 (2007).
   PubMedGoogle Scholar
• Xia CW, Qiu Y, Sun X et al. [Vitamin D receptor gene polymorphisms in female adolescent idiopathic scoliosis patients]. Zhonghua Yi Xue Za Zhi87(21), 1465–1469 (2007).
   PubMedGoogle Scholar
• Xu H, Xiong DH, Xu FH et al. Association between VDR ApaI polymorphism and hip bone mineral density can be modified by body mass index: a study on postmenopausal Chinese women. Acta Biochim. Biophys. Sin. (Shanghai)37(1), 61–67 (2005).
   PubMedGoogle Scholar
• Remes T, Vaisanen SB, Mahonen A et al. Bone mineral density, body height, and vitamin D receptor gene polymorphism in middle-aged men. Ann. Med.37(5), 383–392 (2005).
   PubMed Web of Science ®Google Scholar
• Garnero P, Munoz F, Borel O et al. Vitamin D receptor gene polymorphisms are associated with the risk of fractures in postmenopausal women, independently of bone mineral density. J. Clin. Endocrinol. Metab.90(8), 4829–4835 (2005).
   PubMed Web of Science ®Google Scholar
• Zajickova K, Zofkova I, Hill M. Vitamin D receptor polymorphisms, bone ultrasound and mineral density in post-menopausal women. Aging Clin. Exp. Res.17(2), 121–124 (2005).
   PubMed Web of Science ®Google Scholar
• Rabon-Stith KM, Hagberg JM, Phares DA et al. Vitamin D receptor FokI genotype influences bone mineral density response to strength training, but not aerobic training. Exp. Physiol.90(4), 653–661 (2005).
   PubMedGoogle Scholar
• Falkiewicz K, Bidzinska B, Demissie M et al. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation. Transplant. Proc.37(2), 1023–1025 (2005).
   PubMedGoogle Scholar
• Morita A, Iki M, Dohi Y et al. Effects of the Cdx-2 polymorphism of the vitamin D receptor gene and lifestyle factors on bone mineral density in a representative sample of Japanese women: the Japanese Population-based Osteoporosis (JPOS) Study. Calcif. Tissue Int.77(6), 339–347 (2005).
   PubMed Web of Science ®Google Scholar
• Bolu SE, Orkunoglu Suer FE, Deniz F et al. The vitamin D receptor fokI start codon polymorphism and bone mineral density in male hypogonadotrophic hypogonadism. J. Endocrinol. Invest.28(9), 810–814 (2005).
   PubMedGoogle Scholar
• Abrams SA, Griffin IJ, Hawthorne KM et al. Vitamin D receptor Fok1 polymorphisms affect calcium absorption, kinetics, and bone mineralization rates during puberty. J. Bone Miner. Res.20(6), 945–953 (2005).
   PubMed Web of Science ®Google Scholar
• Horst-Sikorska W, Wawrzyniak A, Celczynska-Bajew L et al. Polymorphism of VDR gene – the most effective molecular marker of osteoporotic bone fractures risk within postmenopausal women from Wielkopolska region of Poland. Endokrynol. Pol.56(3), 233–239 (2005).
   PubMedGoogle Scholar
• Kim TH, Hong JM, Lee JY et al. Promoter polymorphisms of the vascular endothelial growth factor gene is associated with an osteonecrosis of the femoral head in the Korean population. Osteoarthritis Cartilage DOI: 10.1016/j.joca.2007.06.017 (2007).
   Google Scholar
• Dempfle A, Wudy SA, Saar K et al. Evidence for involvement of the vitamin D receptor gene in idiopathic short stature via a genome-wide linkage study and subsequent association studies. Hum. Mol. Genet.15(18), 2772–2783 (2006).
   PubMedGoogle Scholar
• Hsu YH, Xu X, Terwedow HA et al. Large-scale genome-wide linkage analysis for loci linked to BMD at different skeletal sites in extreme selected sibships. J. Bone Miner. Res.22(2), 184–194 (2007).
   PubMedGoogle Scholar
• Ioannidis JP, Ng MY, Sham PC et al. Meta-analysis of genome-wide scans provides evidence for sex- and site-specific regulation of bone mass. J. Bone Miner. Res.22(2), 173–183 (2007).
   PubMedGoogle Scholar
• Qin W, He JX, Shi J et al. [Mutation detection of COL1A1 gene in a pedigree with osteogenesis imperfecta]. Yi Chuan Xue Bao32(3), 248–252 (2005).
   PubMedGoogle Scholar
• Vidal C, Galea R, Brincat M et al. Linkage to chromosome 11p12 in two Maltese families with a highly penetrant form of osteoporosis. Eur. J. Hum. Genet.15(7), 800–809 (2007).
   PubMedGoogle Scholar
• Lee SH, Gupta MK, Han DW et al. Development of transgenic chickens expressing human parathormone under the control of a ubiquitous promoter by using a retrovirus vector system. Poult. Sci.86(10), 2221–2227 (2007).
   PubMedGoogle Scholar
• Akhter MP, Jung LK. Decreased bone strength in HLA-B27 transgenic rat model of spondyloarthropathy. Rheumatology (Oxford)46(8), 1258–1262 (2007).
   PubMedGoogle Scholar
• Ono N, Nakashima K, Schipani E et al. Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption. J. Biol. Chem.282(35), 25509–25516 (2007).
   PubMedGoogle Scholar
• Merciris D, Marty C, Collet C et al. Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo. Am. J. Pathol.170(5), 1676–1685 (2007).
   PubMedGoogle Scholar
• Hiramatsu K, Asaba Y, Takeshita S et al. Overexpression of γ-glutamyltransferase in transgenic mice accelerates bone resorption and causes osteoporosis. Endocrinology148(6), 2708–2715 (2007).
   PubMedGoogle Scholar
• Forlino A, Gualeni B, Pecora F et al. Insights from a transgenic mouse model on the role of SLC26A2 in health and disease. Novartis Found. Symp.273, 193–206 (2006).
   PubMedGoogle Scholar
• Iqbal J, Sun L, Kumar TR et al. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc. Natl Acad. Sci. USA103(40), 14925–14930 (2006).
   PubMed Web of Science ®Google Scholar
• Wei S, Dai XM, Stanley ER. Transgenic expression of CSF-1 in CSF-1 receptor-expressing cells leads to macrophage activation, osteoporosis, and early death. J. Leukoc. Biol.80(6), 1445–1453 (2006).
   PubMedGoogle Scholar
• Merciris D, Schiltz C, Legoupil N et al. Over-expression of TIMP-1 in osteoblasts increases the anabolic response to PTH. Bone40(1), 75–83 (2007).
   PubMed Web of Science ®Google Scholar
• Qin X, Wergedal JE, Rehage M et al. Pregnancy-associated plasma protein-A increases osteoblast proliferation in vitro and bone formation in vivo. Endocrinology147(12), 5653–5661 (2006).
   PubMedGoogle Scholar
• Onodera S, Sasaki S, Ohshima S et al. Transgenic mice overexpressing macrophage migration inhibitory factor (MIF) exhibit high-turnover osteoporosis. J. Bone Miner. Res.21(6), 876–885 (2006).
   PubMedGoogle Scholar
• Winslow MM, Pan M, Starbuck M et al. Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev. Cell10(6), 771–782 (2006).
   PubMed Web of Science ®Google Scholar
• Richard S, Torabi N, Franco GV et al. Ablation of the Sam68 RNA binding protein protects mice from age-related bone loss. PLoS Genet1(6), E74 (2005).
   PubMed Web of Science ®Google Scholar
• Masuda H, Chikuda H, Suga T et al. Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice. Mech. Ageing Dev.126(12), 1274–1283 (2005).
   PubMed Web of Science ®Google Scholar
• Miao D, He B, Jiang Y et al. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1–34. J. Clin. Invest.115(9), 2402–2411 (2005).
   PubMed Web of Science ®Google Scholar
• Pantschenko AG, Zhang W, Nahounou M et al. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice. J. Bone Miner. Res.20(8), 1414–1429 (2005).
   PubMed Web of Science ®Google Scholar
• Forlino A, Piazza R, Tiveron C et al. A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum. Mol. Genet.14(6), 859–871 (2005).
   PubMed Web of Science ®Google Scholar
• Salih DA, Mohan S, Kasukawa Y et al. Insulin-like growth factor-binding protein-5 induces a gender-related decrease in bone mineral density in transgenic mice. Endocrinology146(2), 931–940 (2005).
   PubMed Web of Science ®Google Scholar
• Aoki Y, Ichimura S, Kikuchi T et al. Overexpression of the human interleukin 1a gene causes osteopenia in mice. J. Rheumatol.32(2), 320–324 (2005).
   PubMedGoogle Scholar
• Rubin CJ, Lindberg J, Fitzsimmons C et al. Differential gene expression in femoral bone from red junglefowl and domestic chicken, differing for bone phenotypic traits. BMC Genomics8, 208 (2007).
   PubMedGoogle Scholar
• Conrads KA, Yi M, Simpson KA et al. A combined proteome and microarray investigation of inorganic phosphate-induced pre-osteoblast cells. Mol. Cell. Proteomics4(9), 1284–1296 (2005).
   PubMedGoogle Scholar
• Kahai S, Vary CP, Gao Y et al. Collagen, type V, α1 (COL5A1) is regulated by TGF-β in osteoblasts. Matrix Biol.23(7), 445–455 (2004).
   PubMed Web of Science ®Google Scholar
• Waters KM, Tan R, Genetos DC et al. DNA microarray analysis reveals a role for lysophosphatidic acid in the regulation of anti-inflammatory genes in MC3T3-E1 cells. Bone41(5), 833–841 (2007).
   PubMedGoogle Scholar
• Young DW, Pratap J, Javed A et al. SWI/SNF chromatin remodeling complex is obligatory for BMP2-induced, Runx2-dependent skeletal gene expression that controls osteoblast differentiation. J. Cell. Biochem.94(4), 720–730 (2005).
   PubMedGoogle Scholar
• Hishiya A, Ikeda K, Watanabe K. A RANKL-inducible gene Znf216 in osteoclast differentiation. J. Recept. Signal Transduct. Res.25(3), 199–216 (2005).
   PubMed Web of Science ®Google Scholar
• Vaes BL, Ducy P, Sijbers AM et al. Microarray analysis on Runx2-deficient mouse embryos reveals novel Runx2 functions and target genes during intramembranous and endochondral bone formation. Bone39(4), 724–738 (2006).
   PubMed Web of Science ®Google Scholar
• Liu T, Gao Y, Sakamoto K et al. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines. J. Cell. Physiol.211(3), 728–735 (2007).
   PubMedGoogle Scholar
• Fulzele K, Digirolamo DJ, Liu Z et al. Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action. J. Biol. Chem.282(35), 25649–25658 (2007).
   PubMed Web of Science ®Google Scholar
• Chen XD, Bian X, Teslovich TM et al. Dissection of the sets of genes that control the behavior of biglycan-deficient pre-osteoblasts using oligonucleotide microarrays. Bone37(2), 192–203 (2005).
   PubMedGoogle Scholar
• Fukuoka H, Aoyama M, Miyazawa K et al. Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells. Biochem. Biophys. Res. Commun.328(4), 885–894 (2005).
   PubMed Web of Science ®Google Scholar
• Kawashima N, Shindo K, Sakamoto K et al. Molecular and cell biological properties of mouse osteogenic mesenchymal progenitor cells, Kusa. J. Bone Miner. Metab.23(2), 123–133 (2005).
   PubMed Web of Science ®Google Scholar
• Matsusaki T, Aoyama T, Nishijo K et al. Expression of the cadherin-11 gene is a discriminative factor between articular and growth plate chondrocytes. Osteoarthritis Cartilage14(4), 353–366 (2006).
   PubMedGoogle Scholar
• Watters JW, Cheng C, Pickarski M et al. Inverse relationship between matrix remodeling and lipid metabolism during osteoarthritis progression in the STR/ORT mouse. Arthritis Rheum.56(9), 2999–3009 (2007).
   PubMed Web of Science ®Google Scholar
• Ninomiya K, Miyamoto T, Imai JI et al. Osteoclastic activity induces osteomodulin expression in osteoblasts. Biochem. Biophys. Res. Commun.362(2), 460–466 (2007).
   PubMedGoogle Scholar
• Armstrong VJ, Muzylak M, Sunters A et al. Wnt/β-catenin signaling is a component of osteoblastic bone cell early responses to load-bearing and requires estrogen receptor α. J. Biol. Chem.282(28), 20715–20727 (2007).
   PubMed Web of Science ®Google Scholar
• James CG, Ulici V, Tuckermann J et al. Expression profiling of dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development. BMC Genomics8, 205 (2007).
   PubMed Web of Science ®Google Scholar
• Wan DC, Aalami OO, Wang Z et al. Differential gene expression between juvenile and adult dura mater: a window into what genes play a role in the regeneration of membranous bone. Plast. Reconstr. Surg.118(4), 851–861 (2006).
   PubMedGoogle Scholar
• De BA, Van HP, Bakkus M et al. Migration of culture-expanded human mesenchymal stem cells through bone marrow endothelium is regulated by matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-3. Haematologica92(4), 440–449 (2007).
   PubMed Web of Science ®Google Scholar
• Huttunen MM, Pekkinen M, Ahlstrom ME et al. Effects of bioactive peptides isoleucine-proline-proline (IPP), valine-proline-proline (VPP) and leucine-lysine-proline (LKP) on gene expression of osteoblasts differentiated from human mesenchymal stem cells. Br. J. Nutr.98(4), 780–788 (2007).
   PubMedGoogle Scholar
• Lietman SA, Ding C, Cooke DW et al. Reduction in Gsα induces osteogenic differentiation in human mesenchymal stem cells. Clin. Orthop. Relat. Res.434, 231–238 (2005).
   Google Scholar
• Tang Z, Sahu SN, Khadeer MA et al. Overexpression of the ZIP1 zinc transporter induces an osteogenic phenotype in mesenchymal stem cells. Bone38(2), 181–198 (2006).
   PubMedGoogle Scholar
• Lecka-Czernik B, ckert-Bicknell C, Adamo ML et al. Activation of peroxisome proliferator-activated receptor γ (PPARγ) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo. Endocrinology148(2), 903–911 (2007).
   PubMed Web of Science ®Google Scholar
• Chen S, Santos L, Wu Y et al. Altered gene expression in human cleidocranial dysplasia dental pulp cells. Arch. Oral Biol.50(2), 227–236 (2005).
   PubMedGoogle Scholar
• Hanagata N, Takemura T, Monkawa A et al. Phenotype and gene expression pattern of osteoblast-like cells cultured on polystyrene and hydroxyapatite with pre-adsorbed type-I collagen. J. Biomed. Mater. Res. A83(2), 362–371(2007).
   PubMedGoogle Scholar
• Yamada S, Ganno T, Ohara N et al. Chitosan monomer accelerates alkaline phosphatase activity on human osteoblastic cells under hypofunctional conditions. J. Biomed. Mater. Res. A83(2), 290–295 (2007).
   PubMedGoogle Scholar
• Malizia AP, Vioreanu MH, Doran PP et al. HIV1 protease inhibitors selectively induce inflammatory chemokine expression in primary human osteoblasts. Antiviral Res.74(1), 72–76 (2007).
   PubMedGoogle Scholar
• Christodoulou I, Buttery LD, Tai G et al. Characterization of human fetal osteoblasts by microarray analysis following stimulation with 58S bioactive gel-glass ionic dissolution products. J. Biomed. Mater. Res. B Appl. Biomater.77(2), 431–446 (2006).
   PubMedGoogle Scholar
• Finkenzeller G, Arabatzis G, Geyer M et al. Gene expression profiling reveals platelet-derived growth factor receptor α as a target of cell contact-dependent gene regulation in an endothelial cell-osteoblast co-culture model. Tissue Eng.12(10), 2889–2903 (2006).
   PubMedGoogle Scholar
• Hurson CJ, Butler JS, Keating DT et al. Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis. BMC Musculoskelet. Disord.8, 12 (2007).
   PubMed Web of Science ®Google Scholar
• Malizia AP, Cotter E, Chew N et al. HIV protease inhibitors selectively induce gene expression alterations associated with reduced calcium deposition in primary human osteoblasts. AIDS Res. Hum. Retroviruses23(2), 243–250 (2007).
   PubMedGoogle Scholar
• Carinci F, Piattelli A, Guida L et al. Effects of Emdogain on osteoblast gene expression. Oral Dis.12(3), 329–342 (2006).
   PubMedGoogle Scholar
• Carinci F, Piattelli A, Degidi M et al. Genetic effects of anorganic bovine bone (Bio-Oss) on osteoblast-like MG63 cells. Arch. Oral Biol.51(2), 154–163 (2006).
   PubMedGoogle Scholar
• Kim CS, Sohn SH, Jeon SK et al. Effect of various implant coatings on biological responses in MG63 using cDNA microarray. J. Oral Rehabil.33(5), 368–379 (2006).
   PubMed Web of Science ®Google Scholar
• Sollazzo V, Palmieri A, Pezzetti F et al. Genetic effect of zirconium oxide coating on osteoblast-like cells. J. Biomed. Mater. Res. B Appl. Biomater.84(2), 550–558 (2007).
   Google Scholar
• Tsukahara S, Ikeda R, Goto S et al. Tumour necrosis factor a-stimulated gene-6 inhibits osteoblastic differentiation of human mesenchymal stem cells induced by osteogenic differentiation medium and BMP-2. Biochem. J.398(3), 595–603 (2006).
   PubMedGoogle Scholar